Prognostic impact of Philadelphia chromosome in mixed phenotype acute leukemia ( MPAL ): A cancer registry analysis on real‐world outcome-Reference-Cited by-同舟云学术

Prognostic impact of Philadelphia chromosome in mixed phenotype acute leukemia ( MPAL ): A cancer registry analysis on real‐world outcome

Published:2020-06-28 Issue:9 Volume:95 Page:1015-1021
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am J Hematol

Author:

Qasrawi Ayman¹^ORCID,Ramlal Reshma¹,Munker Reinhold¹,Hildebrandt Gerhard C.¹

Affiliation:

1. Division of Hematology, Blood & Marrow Transplantation University of Kentucky Medical Center, Markey Cancer Center Lexington Kentucky

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ajh.25873

Reference30 articles.

1. Survival of patients with mixed phenotype acute leukemias: A large population-based study

2. Mixed-phenotype acute leukemia: historical overview and a new definition

3. Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL);Bene MC;Leukemia.,1995

4. How I treat mixed-phenotype acute leukemia

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic Factors in Philadelphia Chromosome-Positive Acute Myeloid Leukemia Using Fluorescence in Situ Hybridization;Clinical Laboratory;2024

2. Unmanipulated haploidentical hematopoietic stem cell transplantation for mixed phenotype acute leukemia: a single center study;2023-07-13

3. Multicenter retrospective analysis of clinical outcome of adult patients with mixed-phenotype acute leukemia treated with acute myeloid leukemia–like or acute lymphoblastic leukemia–like chemotherapy and impact of allogeneic stem cell transplantation: a Campus ALL study;Annals of Hematology;2023-03-24

4. Molecular Pathology of Leukemia;Molecular Surgical Pathology;2023

5. Integrative genomic and transcriptomic profiling reveals distinct molecular subsets in adult mixed phenotype acute leukemia;American Journal of Hematology;2022-10-31